RecallHawk

RYANODEX DANTROLENE SODIUM (DANTROLENE SODIUM)

EAGLE PHARMS

Summary

FDA approved RYANODEX DANTROLENE SODIUM (DANTROLENE SODIUM) by EAGLE PHARMS. NDA (New Drug) approval (Labeling) on 2024-04-02. FOR SUSPENSION, INTRAVENOUS.

Details

Source

Drug Approval

External ID

NDA205579-11

Action Date

2024-04-02

Status

Approved

Category

drug

Product Code

NDA (New Drug)

Product Description

RYANODEX DANTROLENE SODIUM (generic: DANTROLENE SODIUM), FOR SUSPENSION, INTRAVENOUS. Application: NDA205579

Context & Analysis

EAGLE PHARMS has 3 FDA actions in our database.

Frequently Asked Questions

How often does EAGLE PHARMS have FDA actions?

EAGLE PHARMS has 3 FDA actions in our database, including 0 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "NDA205579-11" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions